UCB - Current Assets

Stock Price
249.60
Daily Change
-3.00 -1.19%
Monthly
-11.08%
Yearly
38.78%
Q1 Forecast
243.41

UCB reported EUR4.79B in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Alcon AG USD 6.45B 116M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Amarin USD 628.33M 21.52M Sep/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 13.23B 354M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Orion EUR 1.34B 247.2M Dec/2025
Recordati EUR 1.71B 144.32M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024
Unibail Rodamco EUR 7.12B 550.2M Dec/2024